All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-38242020

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38242020	A1630G	X	X	Carcinoma, Hepatocellular	G R C L	View
2	38242020	A1762T	X	X	Carcinoma, Hepatocellular	G R C L	View
3	38242020	A47T	X	X	Carcinoma, Hepatocellular	G R C L	View
4	38242020	G1512A	X	X	Carcinoma, Hepatocellular	G R C L	View
5	38242020	G1764A	X	X	Carcinoma, Hepatocellular	G R C L	View
6	38242020	H86R	X	X	Carcinoma, Hepatocellular	G R C L	View
7	38242020	K130M	X	X	Carcinoma, Hepatocellular	G R C L	View
8	38242020	T1753A	X	X	Carcinoma, Hepatocellular	G R C L	View
9	38242020	T1753C	X	X	Carcinoma, Hepatocellular	G R C L	View
10	38242020	T1753G	X	X	Carcinoma, Hepatocellular	G R C L	View
11	38242020	V131I	X	X	Carcinoma, Hepatocellular	G R C L	View
12	38242020	A453G	S	S	Carcinoma, Hepatocellular	G R C L	View
13	38242020	C1480A	X	X	Carcinoma, Hepatocellular	G R C L	View
14	38242020	C1629T	X	X	Carcinoma, Hepatocellular	G R C L	View
15	38242020	C1653T	X	X	Carcinoma, Hepatocellular	G R C L	View
16	38242020	C2288A	C	C	Carcinoma, Hepatocellular	G R C L	View
17	38242020	C312T	S	S	Carcinoma, Hepatocellular	G R C L	View
18	38242020	C455A	S	S	Carcinoma, Hepatocellular	G R C L	View
19	38242020	F34L	X	X	Carcinoma, Hepatocellular	G R C L	View
20	38242020	G2153A	C	C	Carcinoma, Hepatocellular	G R C L	View
21	38242020	H94Y	X	X	Carcinoma, Hepatocellular	G R C L	View
22	38242020	I126N	S	S	Carcinoma, Hepatocellular	G R I C L	View
23	38242020	I126T	S	S	Carcinoma, Hepatocellular	G R I C L	View
24	38242020	I127N	X	X	Carcinoma, Hepatocellular	G R C L	View
25	38242020	I127S	X	X	Carcinoma, Hepatocellular	G R C L	View
26	38242020	I127T	X	X	Carcinoma, Hepatocellular	G R C L	View
27	38242020	P159T	C	C	Carcinoma, Hepatocellular	G R C L	View
28	38242020	P36H	X	X	Carcinoma, Hepatocellular	G R C L	View
29	38242020	Q101K	S	S	Carcinoma, Hepatocellular	G R C L	View
30	38242020	S53L	S	S	Carcinoma, Hepatocellular	G R C L	View
31	38242020	T1473C	X	X	Carcinoma, Hepatocellular	G R C L	View
32	38242020	T531A	S	S	Carcinoma, Hepatocellular	G R I C L	View
33	38242020	T531C	S	S	Carcinoma, Hepatocellular	G R I C L	View
34	38242020	V114I	C	C	Carcinoma, Hepatocellular	G R C L	View
35	38242020	Y100C	S	S	Carcinoma, Hepatocellular	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.